TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
AUPH

Aurinia Pharmaceuticals Inc

Healthcare · Biotechnology

16.60$ +1.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Aurinia Pharmaceuticals Inc (AUPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 792 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AUPH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
555 548 517 524 549 551 505 503 528 752 724 792
426 425 398 410 440 447 406 409 439 492 480 541
46 49 64 33 37 83 66 53 73 80 41 180
338 350 320 330 349 358 313 315 352 398 379 443
38 24 29 26 36 37 40 40 31 41 49 41
33 40 40 39 39 39 46 47 45 46 46 45
5.3 5.0 4.8 4.6 4.5 4.4 4.2 4.0 3.9 3.8 3.6 3.4
163 170 157 159 161 173 155 167 162 170 156 177
74 77 71 77 79 98 68 78 76 94 87 100
14 16 15 15 16 15 16 17 17 18 18 16
8.9 4.3 5.7 8.4 8.9 5.2 4.2 3.3 2.2 3.3 2.7 1.7
392 378 359 365 388 377 350 335 366 581 568 615
-915 -942 -953 -952 -938 -937 -913 -892 -860 -649 -615 -578
143 144 144 144 146 148 139 143 136 139 138 134

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?